Preventive strategies for TRALI involve careful donor selection and screening, especially avoiding the use of plasma from donors who have been pregnant or who have a history of transfusion-related complications. Leukoreduction of blood products and using male-predominant plasma donors can also reduce the risk. For cancer patients, minimizing unnecessary transfusions and closely monitoring for early signs of TRALI can be effective preventive measures.
